Skip to content

S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain

Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain : Identification of Potential Relevant Biomarkers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03003845
Acronym
S1P1
Enrollment
21
Registered
2016-12-28
Start date
2019-02-26
Completion date
2020-02-27
Last updated
2021-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Cystitis

Brief summary

For each patient in the study, blood, and pain scores will be collected to look for markers for pain, at the start of treatment and 6 months after surgery of treatment.

Detailed description

The study is investigator-initiated, prospective, study. There will be no change in care. Patients who have had a diagnosis of IC made by cystoscopy and hydrodistension and still have pain will be recruited for this study. Patients will have blood samples taken at the visit they sign the consent form and 6 months later. The study staff will call and remind the patient of their 6 month visit.

Interventions

OTHERQuestionnaires

QOL and pain questionnaires will be given to patients at 3, 6, and 12 months post surgery

Blood for PBLs will be collected at 3, 6, and 12 months post surgery

Sponsors

St. Louis University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 18-70 years of age * Patients must be able to provide written informed consent. * Diagnosis of Interstitial Cystitis documented by provider

Exclusion criteria

* age \<18 or \>70 years of age * pregnant

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Pain Scores on the Visual Analog Scale at 6 months3 monthsS1PR1 levels in PBLs can discriminate patients with Interstitial Cystitis pain and patients with other types of pain.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026